West Synchrony prefillable syringe system available at CPHI Southeast Asia

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has announced the availability of its West Synchrony prefillable syringe (PFS) system at CPHI Southeast Asia in Bangkok, Thailand from 8-10 July, 2026. This system marks a significant shift in drug delivery solutions by offering a fully verified platform from a single supplier.

The West Synchrony PFS system solution is designed specifically for biologics and vaccines. It sets a new standard in drug delivery by accelerating syringe selection through its comprehensive performance and regulatory data packages.

“As our biopharmaceutical players in Southeast Asia expand into more complex biologics and vaccine programs, there is a growing need for infrastructure that can support both quality and scale, while reducing technical, regulatory and supply chain complexity,” said Maha Guruswamy, Vice President & Managing Director, Commercial, Asia Pacific. “Integrated solutions like the West Synchrony PFS system help address these challenges, enabling our partners to accelerate development and safely deliver therapies to patients. This is just one example of how West is supporting customers with the expertise and solutions needed to advance their ambitions.”

Key benefits of the West Synchrony PFS system include:

• Design and System-Level Performance: a single design verification and characterization package from West ensures the form, fit and function of the entire PFS system.
• Regulatory Ease with Comprehensive Submission: a streamlined submission process with one system-level drug master file and regulatory package tailored for comprehensive regulatory needs.
• Single Source Supply: single supplier approach, offering make-to-stock and make-to-order supply with low minimum order quantities, ensuring reliability and flexibility.